Literature DB >> 3700416

Reaction of acetaldehyde with hemoglobin.

R C San George, H D Hoberman.   

Abstract

Acetaldehyde reacted with hemoglobin at neutral pH and 37 degrees C to form adducts that were stable to dialysis and that were not reduced by sodium borohydride. Hemoglobin tetramers having 2, 3, and probably 4 molar eq of bound aldehyde were isolated by cation exchange chromatography. The sites of attachment of the aldehyde were the free amino groups of the N-terminal valine residues of the alpha and beta chains of hemoglobin. Derivatization of the beta chains caused a greater increase in the acidity of the hemoglobin than did derivatization of the alpha chains. Derivatization of the beta chains was also preferred over that of the alpha chains. Acetaldehyde derivatives of the N-terminal octapeptide of hemoglobin S (beta sT-1 peptide), Val-Gly-Gly, and tetraglycine were formed readily, contained 1 M eq of acetaldehyde/mol of peptide, and were not reduced by sodium borohydride. In contrast, Ala-Pro-Gly failed to form a 1:1 adduct with acetaldehyde. 13C NMR analysis of the peptide adducts formed with [1,2-13C]acetaldehyde indicated that tetrahedral diastereomeric derivatives were produced. The 13C chemical shifts of the adducts formed between hemoglobin and [1,2-13C]acetaldehyde were identical to those of the peptide adducts although resonances from the individual diastereomeric adducts at each hemoglobin site could not be resolved. The results cited above as well as other evidence indicate that acetaldehyde reacts with the amino termini of hemoglobin to form stable cyclic imidazolidinone derivatives. An exchange of acetaldehyde residues between peptides was also documented.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3700416

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

2.  One-step site-specific modification of native proteins with 2-pyridinecarboxyaldehydes.

Authors:  James I MacDonald; Henrik K Munch; Troy Moore; Matthew B Francis
Journal:  Nat Chem Biol       Date:  2015-03-30       Impact factor: 15.040

3.  Synthesis of hexose-related imidazolidinones: novel glycation products in the Maillard reaction.

Authors:  S Horvat; M Roscić; J Horvat
Journal:  Glycoconj J       Date:  1999-08       Impact factor: 2.916

Review 4.  Screening for alcoholism: techniques and issues.

Authors:  J P Allen; M J Eckardt; J Wallen
Journal:  Public Health Rep       Date:  1988 Nov-Dec       Impact factor: 2.792

5.  Detection of a protein-acetaldehyde adduct in the liver of rats fed alcohol chronically.

Authors:  R C Lin; R S Smith; L Lumeng
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

6.  In vivo detection of intermediate metabolic products of [1-(13) C]ethanol in the brain using (13) C MRS.

Authors:  Yun Xiang; Jun Shen
Journal:  NMR Biomed       Date:  2011-02-11       Impact factor: 4.044

7.  Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.

Authors:  Y Al-Abed; T Mitsuhashi; H Li; J A Lawson; G A FitzGerald; H Founds; T Donnelly; A Cerami; P Ulrich; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

8.  Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption.

Authors:  O Niemelä; T Juvonen; S Parkkila
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

9.  Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c.

Authors:  Shunsuke Kato; Izumi Otaka; Hanako Toyama; Ryota Kusumi; Kazuyuki Takahashi; Mitsuhiko Nara; Yumi Suganuma; Takehiro Sato; Tsukasa Morii; Hiroki Fujita; Hironori Waki
Journal:  Diabetol Int       Date:  2022-07-22

10.  Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity.

Authors:  Fatemeh Bootorabi; Janne Jänis; Jarkko Valjakka; Sari Isoniemi; Pirjo Vainiotalo; Daniela Vullo; Claudiu T Supuran; Abdul Waheed; William S Sly; Onni Niemelä; Seppo Parkkila
Journal:  BMC Biochem       Date:  2008-11-27       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.